Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 108736-35-2
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Aluminum Foil Bag, Drum
Delivery Time: 7-15DAY
Payment Terms: L/C,D/A,D/P,T/T,Western Union,MoneyGram
Supply Ability: G,KG,TON
CAS NO:: |
108736-35-2 |
Appearance:: |
White To Off-white Lyophilized Powder |
Molecular Formula:: |
C54H69N11O10S2 |
Molecular Weight:: |
1096.32000 |
EINECS NO:: |
689-178-4 |
MDL NO:: |
MFCD00133121 |
CAS NO:: |
108736-35-2 |
Appearance:: |
White To Off-white Lyophilized Powder |
Molecular Formula:: |
C54H69N11O10S2 |
Molecular Weight:: |
1096.32000 |
EINECS NO:: |
689-178-4 |
MDL NO:: |
MFCD00133121 |
Product Description:
Product Name: Lanreotide CAS NO: 108736-35-2
Synonyms:
B-naphthyl-D-ala-cys-tyr-D-trp*lys-val-cys-thr am;
Somatuline;
Chemical & Physical Properties:
Appearance: White to off-white lyophilized powder
Assay :≥99.00%
Density: 1.4±0.1 g/cm3
Boiling Point: 1508.2℃ at 760mmHg
Flash Point: 865.9℃
Refractive Index: 1.689
Storage Condition: -20℃
Vapor Pressure: 0mmHg at 25℃
Safety Information:
WGK Germany: 3
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide. Its sequence is H-D-2Nal-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Thr-NH2.
Lanreotide (as lanreotide acetate) is manufactured by Ipsen, and marketed under the trade name Somatuline. It is available in several countries, including the United Kingdom, Australia and Canada, and was approved for sale in the United States by the Food and Drug Administration (FDA) on August 30, 2007.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.
